293 related articles for article (PubMed ID: 27957497)
1. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Mayr C; Beyreis M; Wagner A; Pichler M; Neureiter D; Kiesslich T
Biomed Res Int; 2016; 2016():4805270. PubMed ID: 27957497
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
[TBL] [Abstract][Full Text] [Related]
3. Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.
Høgdall D; O'Rourke CJ; Larsen FO; Zarforoushan S; Christensen TD; Ghazal A; Boisen MK; Muñoz-Garrido P; Johansen JS; Andersen JB
J Hepatol; 2022 Oct; 77(4):1047-1058. PubMed ID: 35750139
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNAs in bladder cancer.
Enokida H; Yoshino H; Matsushita R; Nakagawa M
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs Involved in Inflammatory Breast Cancer: Oncogene and Tumor Suppressors with Possible Targets.
Rezaei Z; Sadri F
DNA Cell Biol; 2021 Mar; 40(3):499-512. PubMed ID: 33493414
[TBL] [Abstract][Full Text] [Related]
6. Genetic alteration regulated by microRNAs in biliary tract cancers.
Wang N; Xia S; Chen K; Xiang X; Zhu A
Crit Rev Oncol Hematol; 2015 Nov; 96(2):262-73. PubMed ID: 26095617
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner A; Mayr C; Bach D; Illig R; Plaetzer K; Berr F; Pichler M; Neureiter D; Kiesslich T
Int J Mol Sci; 2014 Nov; 15(11):20134-57. PubMed ID: 25380521
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.
Wang J; Du Y; Liu X; Cho WC; Yang Y
Biomed Res Int; 2015; 2015():823620. PubMed ID: 26064956
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression.
Zhong XY; Yu JH; Zhang WG; Wang ZD; Dong Q; Tai S; Cui YF; Li H
Gene; 2012 Feb; 493(1):44-51. PubMed ID: 22146319
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact.
Kunz M; Göttlich C; Walles T; Nietzer S; Dandekar G; Dandekar T
Tumour Biol; 2017 Jul; 39(7):1010428317706430. PubMed ID: 28705115
[TBL] [Abstract][Full Text] [Related]
12. Circular RNAs in Cancer.
Lux S; Bullinger L
Adv Exp Med Biol; 2018; 1087():215-230. PubMed ID: 30259369
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on the dysregulated microRNAs in gastric cancer.
Azarbarzin S; Safaralizadeh R; Khojasteh MB; Baghbanzadeh A; Baradaran B
Mol Biol Rep; 2020 Sep; 47(9):7253-7264. PubMed ID: 32776162
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
Lan H; Lu H; Wang X; Jin H
Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets.
Meseure D; Drak Alsibai K; Nicolas A; Bieche I; Morillon A
Biomed Res Int; 2015; 2015():320214. PubMed ID: 26448935
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
18. Impact of microRNA dynamics on cancer hallmarks: An oral cancer scenario.
Manasa VG; Kannan S
Tumour Biol; 2017 Mar; 39(3):1010428317695920. PubMed ID: 28347239
[TBL] [Abstract][Full Text] [Related]
19. Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma.
Zhang L; Yang M; Mayer T; Johnstone B; Les C; Frisch N; Parsons T; Mi QS; Gibson G
Connect Tissue Res; 2017 Mar; 58(2):155-161. PubMed ID: 27267924
[TBL] [Abstract][Full Text] [Related]
20. A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers.
Barbato A; Piscopo F; Salati M; Pollastro C; Evangelista L; Ferrante L; Limongello D; Brillante S; Iuliano A; Reggiani-Bonetti L; Salatiello M; Iaccarino A; Pisapia P; Malapelle U; Troncone G; Indrieri A; Dominici M; Franco B; Carotenuto P
Clin Exp Med; 2024 Apr; 24(1):74. PubMed ID: 38598008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
